Adenocarcinoma in situ and adenocarcinoma of the cervix
Exam relevance: in 2 of more than 150 board exam reports · rank 144
- Specialty
- Gynaecology · Cervix & HPV
- Images
- Endoscopy & gross 1
- Exam relevance
- 2 of more than 150 reports · rank 144
- In the app
- 1 flashcard · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (1)
Endoscopy & grossDefinition
- Cervical adenocarcinoma in situ (AIS) is a pre-invasive lesion of the endocervical glandular epithelium and, because of its morphology, is regarded as the precursor of invasive adenocarcinoma.
- Most invasive adenocarcinomas develop from AIS located within or just proximal to the transformation zone.
Classification
Why this special case matters
- Adenocarcinoma arises from the columnar epithelium of the endocervix.
- Cytology therefore detects it less well — it sits endocervically, outside the classic sampling zone.
- The cytology report then carries the suffix g (glandular), e.g. Pap IIIg or IVa-g.
Adenocarcinoma in situ (AIS)
- What sets it apart from CIN: AIS is more often multifocal and discontinuous ("skip lesions").
- Adenocarcinoma is HPV-associated in the majority, especially HPV 18 and 16.
Occurrence & epidemiology
Epidemiology
- About 80–85 % of cervical cancers are squamous cell carcinomas and most of the rest are adenocarcinomas; the proportion of adenocarcinoma has increased over the past two decades.
- Patients with AIS are on average about 5 years younger than those with early invasive adenocarcinoma, reflecting a window of about 5 years between the two.
Aetiopathogenesis
Aetiology and risk factors
- HPV infection is the cause of most cervical cancers; AIS harbours HPV types similar to those found in invasive adenocarcinoma.
- A coexisting squamous neoplasia is common, found in about 55 % of women with AIS in a meta-analysis of 33 studies, reflecting a shared aetiology.
Clinical features
- AIS is almost always asymptomatic and generally not visible on gross examination.
- The lesions lie within the endocervical canal and the glandular clefts and are often multifocal.
Diagnosis
- AIS is usually detected during work-up of an abnormal cervical smear, often actually because of accompanying squamous cell abnormalities.
- Cytology detects glandular lesions poorly, with a sensitivity of only about 45 % in a cited study; adding an HPV test improves detection.
- The colposcopic appearance of AIS is non-specific, and because of their location in the endocervical canal the lesions are difficult to detect colposcopically.
Treatment principles
- In adenocarcinoma in situ, conisation with clear margins is the first step; because the lesion is often multifocal and endocervical, hysterectomy is usually recommended once childbearing is complete.
- Where fertility is desired, an organ-preserving approach with close follow-up is possible.
- Invasive adenocarcinoma is treated by stage in the same way as cervical cancer: surgically in early stages and with primary chemoradiotherapy when locally advanced, in each case as decided by the tumour board.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: HPV infection · Cervical dysplasia (CIN) · Cervical cancer
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.